These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34564384)

  • 1. Substantively Lowered Levels of Pantothenic Acid (Vitamin B5) in Several Regions of the Human Brain in Parkinson's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Hooper NM; Unwin RD; Cooper GJS
    Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe and Regionally Widespread Increases in Tissue Urea in the Human Brain Represent a Novel Finding of Pathogenic Potential in Parkinson's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Mol Neurosci; 2021; 14():711396. PubMed ID: 34751215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread Decreases in Cerebral Copper Are Common to Parkinson's Disease Dementia and Alzheimer's Disease Dementia.
    Scholefield M; Church SJ; Xu J; Patassini S; Roncaroli F; Hooper NM; Unwin RD; Cooper GJS
    Front Aging Neurosci; 2021; 13():641222. PubMed ID: 33746735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer's disease.
    Xu J; Patassini S; Begley P; Church S; Waldvogel HJ; Faull RLM; Unwin RD; Cooper GJS
    Biochem Biophys Res Commun; 2020 Jun; 527(3):676-681. PubMed ID: 32416962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-regional alterations in glucose and purine metabolic pathways in the Parkinson's disease dementia brain.
    Scholefield M; Church SJ; Taylor G; Knight D; Unwin RD; Cooper GJS
    NPJ Parkinsons Dis; 2023 Apr; 9(1):66. PubMed ID: 37081022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin B5 (d-pantothenic acid) localizes in myelinated structures of the rat brain: Potential role for cerebral vitamin B5 stores in local myelin homeostasis.
    Ismail N; Kureishy N; Church SJ; Scholefield M; Unwin RD; Xu J; Patassini S; Cooper GJS
    Biochem Biophys Res Commun; 2020 Jan; 522(1):220-225. PubMed ID: 31759626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Vitamin B5 (D-Pantothenic Acid) Deficiency as a Potential Cause of Metabolic Perturbation and Neurodegeneration in Huntington's Disease.
    Patassini S; Begley P; Xu J; Church SJ; Kureishy N; Reid SJ; Waldvogel HJ; Faull RLM; Snell RG; Unwin RD; Cooper GJS
    Metabolites; 2019 Jun; 9(6):. PubMed ID: 31212603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of pathological markers in Parkinson's disease dementia post-mortem brains compared to dementia with Lewy bodies.
    Tu H; Zhang ZW; Qiu L; Lin Y; Jiang M; Chia SY; Wei Y; Ng ASL; Reynolds R; Tan EK; Zeng L
    BMC Neurosci; 2022 Jan; 23(1):3. PubMed ID: 34983390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial activity in the frontal cortex area 8 and angular gyrus in Parkinson's disease and Parkinson's disease with dementia.
    Garcia-Esparcia P; Koneti A; Rodríguez-Oroz MC; Gago B; Del Rio JA; Ferrer I
    Brain Pathol; 2018 Jan; 28(1):43-57. PubMed ID: 27984680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders.
    Ge J; Barnes NM
    Eur J Pharmacol; 1996 Feb; 297(3):299-306. PubMed ID: 8666063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
    Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
    Reynolds GP; Mason SL; Meldrum A; De Keczer S; Parnes H; Eglen RM; Wong EH
    Br J Pharmacol; 1995 Mar; 114(5):993-8. PubMed ID: 7780656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-brain regions study of ANK1 DNA methylation in different neurodegenerative diseases.
    Smith AR; Smith RG; Burrage J; Troakes C; Al-Sarraj S; Kalaria RN; Sloan C; Robinson AC; Mill J; Lunnon K
    Neurobiol Aging; 2019 Feb; 74():70-76. PubMed ID: 30439595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease.
    Garcia-Esparcia P; Hernández-Ortega K; Koneti A; Gil L; Delgado-Morales R; Castaño E; Carmona M; Ferrer I
    Acta Neuropathol Commun; 2015 Dec; 3():76. PubMed ID: 26621506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
    Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
    Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography.
    Altar CA; Baudry M
    Exp Neurol; 1990 Sep; 109(3):333-41. PubMed ID: 2209775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson's disease and dementia with Lewy bodies.
    Frigerio I; Bouwman MMA; Noordermeer RTGMM; Podobnik E; Popovic M; Timmermans E; Rozemuller AJM; van de Berg WDJ; Jonkman LE
    Acta Neuropathol Commun; 2024 Jan; 12(1):4. PubMed ID: 38173031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of Distinct Types of Neurons from Fresh Brain Tissue Using Laser Microdissection in Combination with High-Performance Liquid Chromatography-Mass Spectrometry.
    Aring L; Steinbach S; Marcus K; May C
    Methods Mol Biol; 2018; 1723():247-260. PubMed ID: 29344865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.